AAM's adjusted earnings per share in the fourth quarter of 2020 was $0.51 per share.
Adjusted earnings per share for the fourth quarter of 2020 was $0.51 per share versus $0.13 per share in the fourth quarter of 2019.
Taking all of these sales and cost drivers into account, our GAAP net income was $36 million or $0.30 per share in the fourth quarter of 2020 compared to a loss of $454.4 million or a loss of $4.04 per share in the fourth quarter of 2019.
AAM's fourth quarter 2020 sales were $1.44 billion compared to $1.43 billion in the fourth quarter of 2019.
In the fourth quarter of 2020, AAM sales were $1.44 billion, compared to $1.43 billion in the fourth quarter of 2019.
AAM is targeting full year sales between $5.3 billion and $5.5 billion in 2021.
As for sales, we are targeting a range of $5.3 billion to $5.5 billion for 2021.
We expect the launch cadence of this backlog to be $200 million in 2021, $150 million in 2022, and $250 million in 2023.
AAM is targeting adjusted EBITDA of approximately $850 million to $925 million in 2021.
From an EBITDA perspective, we are expecting adjusted EBITDA in the range of $850 million to $925 million.
And AAM is targeting adjusted free cash flow in 2021 of approximately $300 million to $400 million, which contemplates capital spending of approximately 4.5% of sales.
From an adjusted free cash flow perspective, we are targeting approximately $300 million to $400 million in 2021, and the year-over-year walk is very simple.
From an end market perspective, we see production at approximately 15.5 million to 16 million units for our primary North American market.
This sales target is based upon a North American production of 15.5 million to 16 million units, a new business backlog of $200 million and attrition of approximately $100 million.
Pricing came in at $19 million on year-over-year impact.
AAM expects our gross new business backlog, covering the three-year period of 2021 through 2023, to be approximately $600 million.
